DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 97 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $108,000 | -46.0% | 5,365 | 0.0% | 0.00% | -42.9% |
| Q2 2021 | $200,000 | +46.0% | 5,365 | 0.0% | 0.01% | +40.0% |
| Q1 2021 | $137,000 | +8.7% | 5,365 | -6.5% | 0.01% | -16.7% |
| Q4 2020 | $126,000 | +22.3% | 5,739 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $103,000 | -29.5% | 5,739 | 0.0% | 0.01% | -28.6% |
| Q2 2020 | $146,000 | +78.0% | 5,739 | +29.0% | 0.01% | +40.0% |
| Q1 2020 | $82,000 | -16.3% | 4,450 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $98,000 | +53.1% | 4,450 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $64,000 | -8.6% | 4,450 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $70,000 | +7.7% | 4,450 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $65,000 | +66.7% | 4,450 | +22.9% | 0.00% | +50.0% |
| Q4 2018 | $39,000 | -29.1% | 3,620 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $55,000 | +25.0% | 3,620 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $44,000 | – | 3,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |